Cargando…

Possible Enzymatic Downregulation of the Natriuretic Peptide System in Patients with Reduced Systolic Function and Heart Failure: A Pilot Study

BACKGROUND: In patients with reduced systolic function, the natriuretic peptide system affects heart failure (HF) progression, but the expression of key activating (corin) and degrading enzymes (neprilysin) is not well understood. METHODS AND RESULTS: This pilot study (n=48) compared plasma levels o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zaidi, Syed S., Ward, Ryan D., Ramanathan, Kodangudi, Yu, Xinhua, Gladysheva, Inna P., Reed, Guy L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6083548/ https://www.ncbi.nlm.nih.gov/pubmed/30148170 http://dx.doi.org/10.1155/2018/7279036

Ejemplares similares

Soluble (Pro)Renin Receptor Levels Are Regulated by Plasma Renin Activity and Correlated with Edema in Mice and Humans with HFrEF
por: Gladysheva, Inna P., et al.
Publicado: (2022)

Renin Activity in Heart Failure with Reduced Systolic Function—New Insights
por: Sullivan, Ryan D., et al.
Publicado: (2019)

Natriuretic peptides in the detection of preclinical diastolic or systolic dysfunction
por: Luers, Claus, et al.
Publicado: (2010)

Natriuretic peptide pathways in heart failure: further therapeutic possibilities
por: Sangaralingham, S Jeson, et al.
Publicado: (2022)

Falling corin and ANP activity levels accelerate development of heart failure and cardiac fibrosis
por: Gladysheva, Inna P., et al.
Publicado: (2023)

Prognostic value of brain natriuretic peptide in patients with heart failure and reserved left ventricular systolic function
por: GONG, HUI, et al.
Publicado: (2014)

Association between left ventricular global longitudinal strain and natriuretic peptides in outpatients with chronic systolic heart failure
por: Gaborit, F, et al.
Publicado: (2015)

Natriuretic peptide vs. clinical information for diagnosis of left ventricular systolic dysfunction in primary care
por: Koschack, Janka, et al.
Publicado: (2008)

Segmental arterial stiffness in relation to B-type natriuretic peptide with preserved systolic heart function
por: Yen, Chih-Hsuan, et al.
Publicado: (2017)

Heart rate modulates the relationship of augmented systolic blood pressure with the blood natriuretic peptide levels
por: Tomiyama, Hirofumi, et al.
Publicado: (2021)

Diastolic but not systolic dysfunction is associated with troponin and N-terminal pro-brain natriuretic peptide elevation in sepsis
por: Landesberg, G, et al.
Publicado: (2009)

Natriuretic Peptides in Chronic Heart Failure
por: Brunner-La Rocca, Hans-Peter, et al.
Publicado: (2019)

Myocardial tissue Doppler echocardiography and N-terminal B-type natriuretic peptide (NT-proBNP) in diastolic and systolic heart failure
por: Knebel, Fabian, et al.
Publicado: (2008)

B-type natriuretic peptide: powerful predictor of end-stage chronic heart failure in individuals with systolic dysfunction of the systemic right ventricle
por: Hegarova, Marketa, et al.
Publicado: (2016)

B-type natriuretic peptide (BNP) predicts 90-day mortality and need for paracentesis in cirrhotic patients without systolic heart failure
por: Araujo, Tiago, et al.
Publicado: (2021)

Diagnostic accuracy of natriuretic peptide screening for left ventricular systolic dysfunction in the community: systematic review and meta‐analysis
por: Goyder, Clare R., et al.
Publicado: (2023)

Heads and Tails of Natriuretic Peptides: Neuroprotective Role of Brain Natriuretic Peptide
por: Fernández‐Susavila, Héctor, et al.
Publicado: (2017)

Sodium-Glucose Cotransporter-2 Inhibitors Improve Heart Failure with Reduced Ejection Fraction Outcomes by Reducing Edema and Congestion
por: Hernandez, Michelle, et al.
Publicado: (2022)

Rosiglitazone improves the natriuretic response to atrial natriuretic peptide in rats with experimental congestive heart failure: possible involvement of a post-guanylate cyclase mechanism
por: Goltsman, Ilia, et al.
Publicado: (2011)

Suppression of Cardiogenic Edema with Sodium–Glucose Cotransporter-2 Inhibitors in Heart Failure with Reduced Ejection Fraction: Mechanisms and Insights from Pre-Clinical Studies
por: Sullivan, Ryan D., et al.
Publicado: (2022)

Superiority of proatrial natriuretic peptide in the prognostic power in patients with acute decompensated heart failure on hospital admission: comparison with B-type natriuretic peptide and other natriuretic peptide forms
por: Takashio, Seiji, et al.
Publicado: (2019)

Taipan Natriuretic Peptides Are Potent and Selective Agonists for the Natriuretic Peptide Receptor A
por: Vink, Simone, et al.
Publicado: (2023)

Utility of point-of-care testing of natriuretic peptides (brain natriuretic peptide and n-terminal pro-brain natriuretic peptide) in the emergency department
por: Nayer, Jamshed, et al.
Publicado: (2014)

N-terminal Pro-Brain Natriuretic Peptide Levels Predict Left Ventricular Systolic Function in Patients with Chronic Kidney Disease
por: Lee, Jung Eun, et al.
Publicado: (2009)

Elevated N-terminal pro-B-type natriuretic peptide levels and normal left ventricular systolic function: an echocardiographic study
por: Turley, A, et al.
Publicado: (2005)

N-terminal pro-B-type natriuretic peptide and the diagnosis of left ventricular systolic dysfunction: what is the optimal cut-off?
por: Turley, A, et al.
Publicado: (2005)

Enhanced heart failure, mortality and renin activation in female mice with experimental dilated cardiomyopathy
por: Tripathi, Ranjana, et al.
Publicado: (2017)

In Experimental Dilated Cardiomyopathy Heart Failure and Survival Are Adversely Affected by a Lack of Sexual Interactions
por: Tripathi, Ranjana, et al.
Publicado: (2020)

Possible identification of novel natriuretic peptide receptor phosphorylation sites by alanine/glutamate mutagenesis
por: Yoder, Andrea R, et al.
Publicado: (2009)

Cardiac Natriuretic Peptides: Contributors to Cardiac Cachexia or Possible Anti-obesity Agents or Both?
por: Costello-Boerrigter, Lisa C.
Publicado: (2012)

Advances and Challenges in Diagnosis and Management of Heart Failure
por: Sullivan, Ryan D., et al.
Publicado: (2022)

Relationship between B-type natriuretic peptide serum level, echocardiographic TEI index and the degree of diastolic dysfunction in patients with heart failure with preserved systolic function
por: Karasek, Danuta, et al.
Publicado: (2011)

A novel natriuretic peptide
por: Höfeld, Hanna, et al.
Publicado: (2011)

Natriuretic peptides and fat metabolism
por: Collins, Sheila
Publicado: (2013)

Natriuretic peptides in cardiovascular diseases
por: Piechota, Mariusz, et al.
Publicado: (2008)

Natriuretic Peptides, Cardio-Oncology…
Publicado: (2023)

A Low-Sodium Diet Boosts Ang (1–7) Production and NO-cGMP Bioavailability to Reduce Edema and Enhance Survival in Experimental Heart Failure
por: Tripathi, Ranjana, et al.
Publicado: (2021)

Effects of glutamine and valsartan on the brain natriuretic peptide and N-terminal pro-B-type natriuretic peptide of patients with chronic heart failure
por: Shao, Mingliang, et al.
Publicado: (2015)

Efficacy of exogenous atrial natriuretic peptide in patients with heart failure with preserved ejection fraction: deficiency of atrial natriuretic peptide and replacement therapy
por: Matsumoto, Shingo, et al.
Publicado: (2020)

Normalizing Plasma Renin Activity in Experimental Dilated Cardiomyopathy: Effects on Edema, Cachexia, and Survival
por: Sullivan, Ryan D., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_sqsqv5slo254k7eqr62m5595dd